The Latest Cardiac and Vascular News
ALISO VIEJO, Calif., Sept. 29, 2022 /PRNewswire/ — MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associates in a small facility in Southern California, MicroVention is now a worldwide community with over 3,000 […]
PARIS–(BUSINESS WIRE)–ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical-stage biotechnology company developing innovative drugs for the treatment of cardiovascular emergencies, particularly stroke, today announced the enrollment of the first patient in the USA in its Phase 2/3 registration study ACTISAVE, which is evaluating glenzocimab in patients with acute ischemic […]
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target enrollment (948 patients). The independent data monitoring committee (IDMC) has completed interim analysis and indicated that the trial should continue. The […]
Study marks world’s first trial on robotic-assisted neurovascular aneurysm embolization NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular […]
The fast, accurate, and proven RapidAI platform improves patient and staff experience and diagnostic accuracy, ensures high care team coordination, better health outcomes, and reduces costs. SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ — Frost & Sullivan recently analyzed the artificial intelligence (AI) algorithms for the stroke market, and, based on its assessment results, recognizes RapidAI with […]
This is the second Fast Track designation issued by the FDA for abelacimab Abelacimab is a dual-acting, once-monthly, fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity CAMBRIDGE, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for […]
– Abbott’s Talisman system seals an opening in the heart known as a “patent foramen ovale” (PFO) to prevent blood clots from passing from the right to the left side of the heart and on to the brain, where they can cause a stroke – The Talisman system builds on […]
REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 […]
Physicians in Europe now have access to Penumbra’s latest stroke technology for mechanical thrombectomy RED® reperfusion catheters are designed with optimized trackability and aspiration efficiency to help navigate the complex anatomy of the brain and deliver powerful aspiration for the removal of blood clots Initial INSIGHT Registry data presented at WFITN […]
BOSTON, Aug. 29, 2022 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced completion of the first eShunt® procedure in the United States. The study, ‘US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus (NPH)’, is being conducted under an investigational device […]
